New weight drug tested in humans for first time
NCT ID NCT06144684
Summary
This early-stage study tested the safety of an experimental drug called GUB014295 in healthy but overweight adults. Researchers gave single and multiple doses to 76 participants to see how their bodies reacted and processed the medication. The main goal was to check for side effects while also measuring small changes in weight and metabolism.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quotient Sciences
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.